Cover Image
市場調查報告書

centrose llc :產品平台分析

Centrose LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293907
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
centrose llc :產品平台分析 Centrose LLC - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 25 Pages
簡介

centrose llc 是對患病組織作選擇性標靶的醫藥品進行開發的生物科技企業。該公司的產品,是以成為許多固態腫瘤的再循環和歸巢、多重抗藥性、淋巴球活躍、轉移的原因和以癌症細胞表面為標靶的產品。

本報告提供centrose llc 的治療藥開發平台的現狀及最新更新的各開發階段比較分析、企業和研究機關最新的新聞和發表、正在開發的治療藥、治療藥的評估、後期階段及中止的計劃相關資訊等。

centrose llc的基本資料

  • centrose llc概要
  • 主要資訊
  • 企業資料

centrose llc :R&D概要

  • 主要的治療範圍

centrose llc :開發平台(管線)的檢討

  • 各開發階段的開發中產品
  • 單劑產品

centrose llc :開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

centrose llc :開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

centrose llc :藥物簡介

  • EDC-1
  • EDC-2
  • EDC-3
  • EDC-5
  • EDC-8

centrose llc :開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

centrose llc :最近的開發平台趨勢

centrose llc :暫停中的計劃

centrose llc :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07771CDB

Summary

Global Markets Direct's, 'Centrose LLC - Product Pipeline Review - 2015', provides an overview of the Centrose LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Centrose LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Centrose LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Centrose LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Centrose LLC's pipeline products

Reasons to buy

  • Evaluate Centrose LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Centrose LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Centrose LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Centrose LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Centrose LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Centrose LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Centrose LLC Snapshot
    • Centrose LLC Overview
    • Key Information
    • Key Facts
  • Centrose LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Centrose LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Centrose LLC - Pipeline Products Glance
    • Centrose LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Centrose LLC - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Centrose LLC - Drug Profiles
    • EDC-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDC-2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDC-8
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EDC-9
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Centrose LLC - Pipeline Analysis
    • Centrose LLC - Pipeline Products by Target
    • Centrose LLC - Pipeline Products by Molecule Type
    • Centrose LLC - Pipeline Products by Mechanism of Action
  • Centrose LLC - Recent Pipeline Updates
  • Centrose LLC - Dormant Projects
  • Centrose LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Centrose LLC, Key Information
  • Centrose LLC, Key Facts
  • Centrose LLC - Pipeline by Indication, 2015
  • Centrose LLC - Pipeline by Stage of Development, 2015
  • Centrose LLC - Monotherapy Products in Pipeline, 2015
  • Centrose LLC - Preclinical, 2015
  • Centrose LLC - Discovery, 2015
  • Centrose LLC - Unknown, 2015
  • Centrose LLC - Pipeline by Target, 2015
  • Centrose LLC - Pipeline by Molecule Type, 2015
  • Centrose LLC - Pipeline Products by Mechanism of Action, 2015
  • Centrose LLC - Recent Pipeline Updates, 2015
  • Centrose LLC - Dormant Developmental Projects,2015

List of Figures

  • Centrose LLC - Pipeline by Top 10 Indication, 2015
  • Centrose LLC - Pipeline by Stage of Development, 2015
  • Centrose LLC - Monotherapy Products in Pipeline, 2015
  • Centrose LLC - Pipeline by Top 10 Target, 2015
  • Centrose LLC - Pipeline by Top 10 Molecule Type, 2015
  • Centrose LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top